Khê Hoang-Xuan Selected Research

Khê Hoang-Xuan Research Topics

Disease

43	Neoplasms (Cancer) 04/2024 - 11/2004
27	Lymphoma (Lymphomas) 04/2024 - 02/2004
26	Glioma (Gliomas) 10/2022 - 08/2005
13	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 04/2003
7	Brain Neoplasms (Brain Tumor) 05/2023 - 05/2004
7	Oligodendroglioma 11/2016 - 05/2004
3	Infections 09/2021 - 06/2015
3	Cognitive Dysfunction 06/2020 - 12/2015
3	Carcinogenesis 01/2019 - 09/2008
3	Astrocytoma (Pilocytic Astrocytoma) 11/2016 - 04/2012
3	Intraocular Lymphoma 11/2012 - 02/2004
2	Residual Neoplasm 04/2024 - 01/2023
2	COVID-19 09/2021 - 01/2021
2	Lymphopenia (Lymphocytopenia) 01/2021 - 06/2015
2	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 12/2011 - 04/2008
1	Water Intoxication 01/2024
1	Head and Neck Neoplasms (Head and Neck Cancer) 05/2023
1	Necrosis 01/2023
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 08/2022
1	Neutropenia 01/2021
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2020
1	Inflammation (Inflammations) 12/2020
1	Turcot syndrome 01/2020
1	Neuroepithelial Neoplasms (Gliomatosis Cerebri) 12/2019
1	Aseptic Meningitis 01/2019
1	Vision Disorders (Hemeralopia) 11/2017
1	Meningioma (Meningiomas) 09/2017
1	Hemangiopericytoma 09/2017
1	Solitary Fibrous Tumors 09/2017
1	Erdheim-Chester Disease 01/2017
1	Fatigue 11/2016
1	Virus Diseases (Viral Diseases) 11/2016
1	HIV Infections (HIV Infection) 11/2016
1	Chronic Hepatitis B 11/2016
1	Hypoxia (Hypoxemia) 01/2016

Drug/Important Bio-Agent (IBA)

15	Biomarkers (Surrogate Marker)IBA 04/2024 - 09/2007
13	Temozolomide (Temodar)FDA LinkGeneric 01/2021 - 12/2006
8	Methotrexate (Mexate)FDA LinkGeneric 02/2024 - 05/2008
5	Procarbazine (Matulane)FDA Link 10/2022 - 01/2013
5	Vincristine (Oncovin)FDA LinkGeneric 10/2022 - 01/2013
5	DNA (Deoxyribonucleic Acid)IBA 09/2015 - 04/2012
3	Rituximab (Mabthera)FDA Link 01/2023 - 06/2017
3	Lomustine (CCNU)FDA Link 10/2022 - 01/2013
3	ParaffinIBA 09/2014 - 01/2006
3	Codon (Codons)IBA 02/2013 - 07/2007
2	ibrutinibIBA 01/2021 - 01/2017
2	Lenalidomide (CC 5013)FDA Link 01/2021 - 01/2015
2	Interleukin-10 (Interleukin 10)IBA 01/2019 - 01/2016
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 03/2018 - 04/2008
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2018 - 02/2013
2	Cytarabine (Cytosar-U)FDA LinkGeneric 06/2017 - 06/2015
2	RNA (Ribonucleic Acid)IBA 01/2017 - 08/2009
2	5- (2'- naphthyl)- 7- 4- chlorophenyl- (2,3,6,8- tetrahydro)pyrrolo- (3,4- e)(1,4)- diazepine- 6- thioxo- 8- (1H,7H)oneIBA 01/2017 - 03/2016
2	Proteins (Proteins, Gene)FDA Link 12/2014 - 11/2007
2	Complement System Proteins (Complement)IBA 09/2014 - 11/2004
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2013 - 09/2008
2	Bevacizumab (Avastin)FDA Link 05/2012 - 09/2008
2	Irinotecan (Camptosar)FDA LinkGeneric 05/2012 - 09/2008
2	Protons (Proton)IBA 03/2012 - 04/2008
2	Monoclonal AntibodiesIBA 09/2008 - 08/2005
2	ErbB Receptors (EGF Receptor)IBA 08/2008 - 08/2005
2	Alkylating AgentsIBA 11/2007 - 06/2007
1	SteroidsIBA 04/2024
1	glucarpidaseIBA 01/2024
1	Leucovorin (Folinic Acid)FDA Link 01/2024
1	Immune Checkpoint InhibitorsIBA 12/2022
1	Somatotropin Receptors (Growth Hormone Receptor)IBA 01/2022
1	VaccinesIBA 01/2021
1	mRNA VaccinesIBA 01/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021
1	COVID-19 VaccinesIBA 01/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 12/2020
1	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 01/2020
1	Mitogen-Activated Protein KinasesIBA 12/2019
1	Trastuzumab (Herceptin)FDA Link 01/2019
1	ChromatinIBA 01/2019
1	hemoglobin ASIBA 01/2019
1	CytokinesIBA 12/2017
1	Retinaldehyde (Retinal)IBA 11/2017
1	RG7112IBA 03/2016
1	Carboplatin (JM8)FDA LinkGeneric 01/2016
1	InterleukinsIBA 01/2016
1	Interleukin-6 (Interleukin 6)IBA 01/2016
1	Glutamic Acid (Glutamate)FDA Link 01/2016

Therapy/Procedure

34	Drug Therapy (Chemotherapy) 02/2024 - 04/2003
18	Radiotherapy 06/2023 - 04/2003
8	Therapeutics 12/2022 - 02/2004
3	Stem Cell Transplantation 11/2022 - 01/2019
2	Chemoradiotherapy 10/2022 - 06/2020
2	Aftercare (After-Treatment) 01/2021 - 01/2020
1	Renal Dialysis (Hemodialysis) 01/2024
1	Hemofiltration 01/2024
1	Time-to-Treatment 01/2023
1	Precision Medicine 01/2022
1	Artificial Respiration (Mechanical Ventilation) 09/2021
1	Re-Irradiation 01/2020
1	Biological Therapy 12/2017
1	Contraindications 09/2017
1	Investigational Therapies (Experimental Therapy) 01/2017
1	Oral Administration 11/2016